Stay updated on Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial

Sign up to get notified when there's something new on the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update in the immune response data related to different vaccination schedules of a Tetravalent Dengue Vaccine in healthy subjects aged 9 to 50 years.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:36.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying age, health condition, and consent requirements, among other factors. Previously, this section had no information provided.
    Difference
    25%
    Check dated 2024-05-22T21:20:09.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:40:16.000Z thumbnail image

Stay in the know with updates to Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page.